Search research articles
Contact Us
Filters
Showing results (1-10 of 39) with videos related to
Page
of 4
Sort By:
Pharmacological Research
|
May 8, 1998
Potential therapeutic value of drugs inhibiting semicarbazide-sensitive amine oxidase: vascular cytoprotection in diabetes mellitus
J Ekblom
Pharmacology & Toxicology
|
December 3, 1998
Cytoprotection by deprenyl and tolcapone in a cell culture model of cerebral ischaemia
J Ekblom, O Tottmar, L Oreland
Life Sciences
|
February 24, 2001
Chronic pharmacological treatment with certain antidepressants alters the expression and DNA-binding activity of transcription factor AP-2
M Damberg, J Ekblom, L Oreland
Biochemical Pharmacology
|
March 27, 1998
Regulation of methionine adenosyltransferase catalytic activity and messenger RNA in SH-SY5Y human neuroblastoma cells
C Gomes Trolin, J Ekblom, L Oreland
Molecular Neurobiology
|
August 1, 1994
Growth factor receptors in amyotrophic lateral sclerosis
A Adem, J Ekblom, P G Gillberg
Advances in Pharmacology (San Diego, Calif.)
|
November 5, 1997
Biological markers, with special regard to platelet monoamine oxidase (trbc-MAO), for personality and personality disorders
L Oreland, J Ekblom, H Garpenstrand, et al.
Acta Psychiatrica Scandinavica
|
November 14, 1997
Platelet monoamine oxidase activity in relation to alleles of dopamine D4 receptor and tyrosine hydroxylase genes
H Garpenstrand, J Ekblom, J Hallman, et al.
Experimental Neurology
|
October 1, 1993
Differential increases in catecholamine metabolizing enzymes in amyotrophic lateral sclerosis
J Ekblom, S M Aquilonius, S S Jossan
Life Sciences
|
September 28, 1998
Is there a "non-MAO" macromolecular target for L-deprenyl?: Studies on MAOB mutant mice
J Ekblom, L Oreland, K Chen, et al.
Neurobiology (Budapest, Hungary)
|
November 4, 2000
An autoradiographic method of visualising semicarbazide-sensitive amine oxidase activity in mouse tissue sections
J L Grönvall, H Garpenstrand, L Oreland, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 39) with videos related to
Sort By:
Page
of 4
Pharmacological Research
|
May 8, 1998
Potential therapeutic value of drugs inhibiting semicarbazide-sensitive amine oxidase: vascular cytoprotection in diabetes mellitus
J Ekblom
Pharmacology & Toxicology
|
December 3, 1998
Cytoprotection by deprenyl and tolcapone in a cell culture model of cerebral ischaemia
J Ekblom, O Tottmar, L Oreland
Life Sciences
|
February 24, 2001
Chronic pharmacological treatment with certain antidepressants alters the expression and DNA-binding activity of transcription factor AP-2
M Damberg, J Ekblom, L Oreland
Biochemical Pharmacology
|
March 27, 1998
Regulation of methionine adenosyltransferase catalytic activity and messenger RNA in SH-SY5Y human neuroblastoma cells
C Gomes Trolin, J Ekblom, L Oreland
Molecular Neurobiology
|
August 1, 1994
Growth factor receptors in amyotrophic lateral sclerosis
A Adem, J Ekblom, P G Gillberg
Advances in Pharmacology (San Diego, Calif.)
|
November 5, 1997
Biological markers, with special regard to platelet monoamine oxidase (trbc-MAO), for personality and personality disorders
L Oreland, J Ekblom, H Garpenstrand, et al.
Acta Psychiatrica Scandinavica
|
November 14, 1997
Platelet monoamine oxidase activity in relation to alleles of dopamine D4 receptor and tyrosine hydroxylase genes
H Garpenstrand, J Ekblom, J Hallman, et al.
Experimental Neurology
|
October 1, 1993
Differential increases in catecholamine metabolizing enzymes in amyotrophic lateral sclerosis
J Ekblom, S M Aquilonius, S S Jossan
Life Sciences
|
September 28, 1998
Is there a "non-MAO" macromolecular target for L-deprenyl?: Studies on MAOB mutant mice
J Ekblom, L Oreland, K Chen, et al.
Neurobiology (Budapest, Hungary)
|
November 4, 2000
An autoradiographic method of visualising semicarbazide-sensitive amine oxidase activity in mouse tissue sections
J L Grönvall, H Garpenstrand, L Oreland, et al.
Page
of 4